Developing drugs to sell off
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT05765955
Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 22, 2022
Completion: Dec 16, 2022
Loading map...